Literature DB >> 1929857

Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro.

G Moretto1, S Monaco, M G Passarin, M D Benedetti, N Rizzuto.   

Abstract

Dissociated dorsal root ganglion cells from human fetuses were exposed to 2,5-hexanedione (2,5-HD) for 2 weeks. Morphological changes induced by 2,5-HD consisted in focal neurofilament (NF)-containing enlargements preferentially located in distal, preterminal regions of unmyelinated fibers. Tangles of NF were also observed in the perikarya of nerve cells. Morphometric analysis disclosed that the cross-sectional areas of the 2,5-HD treated axons were 30% smaller than those of control axons. This alteration was associated with reduction of number of NF per unit area. These findings demonstrate that 2,5-HD treatment induces a generalized disorganization of neuronal and axonal NF responsible for focal enlargements as well as atrophic changes of unmyelinated fibers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929857     DOI: 10.1007/bf02284265

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  23 in total

1.  Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter.

Authors:  S Monaco; L Autilio-Gambetti; R J Lasek; M J Katz; P Gambetti
Journal:  J Neuropathol Exp Neurol       Date:  1989-01       Impact factor: 3.685

2.  Cytoskeletal changes induced in vitro by 2,5-hexanedione: an immunocytochemical study.

Authors:  W Malorni; F Iosi; G Formisano; G Arancia
Journal:  Exp Mol Pathol       Date:  1989-02       Impact factor: 3.362

3.  Hexahydrocarbon effects on intermediate filament organization in human fibroblasts.

Authors:  H D Durham; S D Peña; D J Ecobichon
Journal:  Muscle Nerve       Date:  1988-02       Impact factor: 3.217

4.  Slowing of the axonal transport of neurofilament proteins during development.

Authors:  P N Hoffman; R J Lasek; J W Griffin; D L Price
Journal:  J Neurosci       Date:  1983-08       Impact factor: 6.167

5.  Giant axonal neuropathy: an inborn error of organization of intermediate filaments.

Authors:  S D Pena
Journal:  Muscle Nerve       Date:  1982-02       Impact factor: 3.217

6.  Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking.

Authors:  D G Graham; D C Anthony; K Boekelheide; N A Maschmann; R G Richards; J W Wolfram; B R Shaw
Journal:  Toxicol Appl Pharmacol       Date:  1982-07       Impact factor: 4.219

7.  Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.

Authors:  P S Spencer; H H Schaumburg
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

Review 8.  Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments.

Authors:  L M Sayre; L Autilio-Gambetti; P Gambetti
Journal:  Brain Res       Date:  1985-09       Impact factor: 3.252

9.  In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.

Authors:  D G Graham; G Szakál-Quin; J W Priest; D C Anthony
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy.

Authors:  D M Lapadula; E Suwita; M B Abou-Donia
Journal:  Brain Res       Date:  1988-08-16       Impact factor: 3.252

View more
  1 in total

1.  Expression of Bcl-2, Bax and Caspase-3 in nerve tissues of rats chronically exposed to 2,5-hexanedione.

Authors:  Ning Cui; Shanxia Li; Xiulan Zhao; Tianliang Zhang; Cuili Zhang; Lihua Yu; Zhengping Zhu; Keqin Xie
Journal:  Neurochem Res       Date:  2007-05-11       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.